Today's Top Stories


Hot Topics


Comment & Analysis »

Aninda Chakraborty

November's top stories: Patheon to buy API facility, UK NICE approved Celgene’s drug

Patheon agreed to acquire a new API manufacturing facility in the US, and UK NICE approved Celgene’s Imnovid drug for use in relapsed myeloma patients. Pharmaceutical-technology.com wraps up...

November's top stories: Patheon to buy API facility, UK NICE approved Celgene’s drug
GlobalData Healthcare

Keytruda data fuels debate over PD-L1 as a biomarker in metastatic bladder cancer

Keytruda data fuels debate over PD-L1 as a biomarker in metastatic bladder cancer
 

Pfizer’s big antibiotic buyout: a sign of things to come?

Pfizer’s big antibiotic buyout: a sign of things to come?

Ketamine: taking aim at depression

Ketamine: taking aim at depression
 

Pharma Technology Focus – Issue 53

Pharma Technology Focus – Issue 53

Company Releases »

High-Quality Air Treatment Solutions for Pharma Production

Munters
High-Quality Air Treatment Solutions for Pharma Production

Tricalcium Citrate: an Excipient for Direct Compression

Jungbunzlauer Tricalcium Citrate: an Excipient for Direct Compression

Active Pharmaceutical Ingredients and Excipients

Jungbunzlauer
Active Pharmaceutical Ingredients and Excipients

Origin Hybrid Pharmaceutical Packaging (HP3) Brochure

Origin Pharma Packaging Origin Hybrid Pharmaceutical Packaging (HP3) Brochure

Pharmaceutical Insights »

Pharmaceutical Industry Reports »

Report: Israeli pharmaceutical market to grow at compound annual growth rate of 3.9%

Report: Israeli pharmaceutical market to grow at compound annual growth rate of 3.9%

Report: Non-small-cell lung cancer market to reach $20bn by 2025

Report: Non-small-cell lung cancer market to reach $20bn by 2025

Report: Myelofibrosis market to grow at the compound annual growth rate of 6.4% by 2025

Report: Myelofibrosis market to grow at the compound annual growth rate of 6.4% by 2025

Report: Novel pipeline products to drive schizophrenia market growth

Report: Novel pipeline products to drive schizophrenia market growth








cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_-1100201212